ArticleJournal of medicinal chemistry2025

Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective Inhibitor.

Sebastian Mandel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.